Literature DB >> 18006453

Direct intramyocardial injection of mesenchymal stem cell sheet fragments improves cardiac functions after infarction.

Chung-Chi Wang1, Chun-Hung Chen, Wei-Wen Lin, Shiaw-Min Hwang, Patrick C H Hsieh, Po-Hong Lai, Yi-Chun Yeh, Yen Chang, Hsing-Wen Sung.   

Abstract

AIMS: Cell transplantation is a promising approach for patients with myocardial infarction. However, following injection, retention of the transplanted cells in the injected area remains a central issue, which can be deleterious to cell transplantation therapy. We hypothesized that the use of cell sheet fragments, with the preservation of extracellular matrix (ECM), may significantly increase cell retention and thus improve cell therapy. METHODS AND
RESULTS: Mesenchymal stem cell (MSC) sheet fragments with ECM were fabricated. Experimental myocardial infarction was created in male syngeneic Lewis rats. Thirty minutes after myocardial infarction, an intramyocardial injection was conducted with a needle directly into the peri-infarct areas. There were four treatment groups (n > or = 10): sham; phosphate buffered saline; dissociated MSCs; and MSC sheet fragments. Echocardiography and pressure measurements were assessed postoperatively. At retrieval, the hearts were fixed for histological evaluation. After injection, the MSC sheet fragments remained intact, while the complete cell sheets were torn into pieces. The results obtained in the echocardiography and pressure measurements revealed a superior heart function in the MSC sheet fragment group compared with the dissociated MSC group (P < 0.05). The MSC sheet fragments were able to conform and align their inherent ECM along the interstices of the muscular tissues at the injection sites, while only a few cells were identified in the dissociated MSC group at 12 weeks postoperatively. Additionally, transplantation of the MSC sheet fragments stimulated a significant increase in vascular density (P < 0.05) and enhanced the graft/host cell connection.
CONCLUSION: The MSC sheet fragments may serve as a cell delivery vehicle by providing a favourable ECM environment to retain the transplanted cells and improve the efficacy of therapeutic cell transplantation.

Entities:  

Mesh:

Year:  2007        PMID: 18006453     DOI: 10.1093/cvr/cvm046

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  27 in total

1.  Low oxygen tension and synthetic nanogratings improve the uniformity and stemness of human mesenchymal stem cell layer.

Authors:  Feng Zhao; Jan J Veldhuis; Yajun Duan; Yong Yang; Nicolas Christoforou; Teng Ma; Kam W Leong
Journal:  Mol Ther       Date:  2010-02-23       Impact factor: 11.454

2.  Cell sheet injection as a technique of osteogenic supply.

Authors:  M Akahane; T Ueha; T Shimizu; H Shigematsu; A Kido; S Omokawa; K Kawate; T Imamura; Y Tanaka
Journal:  Int J Stem Cells       Date:  2010-05       Impact factor: 2.500

3.  Minimally Invasive Delivery of 3D Shape Recoverable Constructs with Ordered Structures for Tissue Repair.

Authors:  Shixuan Chen; Mark Alan Carlson; Xiaowei Li; Aleem Siddique; Wuqiang Zhu; Jingwei Xie
Journal:  ACS Biomater Sci Eng       Date:  2021-04-30

Review 4.  Can the outcomes of mesenchymal stem cell-based therapy for myocardial infarction be improved? Providing weapons and armour to cells.

Authors:  Andrey A Karpov; Daria V Udalova; Michael G Pliss; Michael M Galagudza
Journal:  Cell Prolif       Date:  2016-11-23       Impact factor: 6.831

Review 5.  Intra-myocardial biomaterial injection therapy in the treatment of heart failure: Materials, outcomes and challenges.

Authors:  Devin M Nelson; Zuwei Ma; Kazuro L Fujimoto; Ryotaro Hashizume; William R Wagner
Journal:  Acta Biomater       Date:  2010-07-07       Impact factor: 8.947

6.  Engineered Tissue Patch for Cardiac Cell Therapy.

Authors:  Jianyi Zhang
Journal:  Curr Treat Options Cardiovasc Med       Date:  2015-08

7.  Delivering stem cells to the heart in a collagen matrix reduces relocation of cells to other organs as assessed by nanoparticle technology.

Authors:  Wangde Dai; Sharon L Hale; Gregory L Kay; Aarne J Jyrala; Robert A Kloner
Journal:  Regen Med       Date:  2009-05       Impact factor: 3.806

Review 8.  Mesenchymal stem cells for vascular regeneration.

Authors:  Ngan F Huang; Song Li
Journal:  Regen Med       Date:  2008-11       Impact factor: 3.806

9.  Bone marrow-derived mesenchymal stem cells in fibrin augment angiogenesis in the chronically infarcted myocardium.

Authors:  Ngan F Huang; Amy Lam; Qizhi Fang; Richard E Sievers; Song Li; Randall J Lee
Journal:  Regen Med       Date:  2009-07       Impact factor: 3.806

Review 10.  Mesenchymal stromal cells: current understanding and clinical status.

Authors:  Husein K Salem; Chris Thiemermann
Journal:  Stem Cells       Date:  2010-03-31       Impact factor: 6.277

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.